PA
Perceptive Advisors Portfolio holdings
AUM
$5.46B
1-Year Est. Return
264.28%
This Fund
S&P 500
1 Year Est. Return
+264.28%
AUM
$5.46B
AUM Growth
+$2B
(+58%)
Holding
131
Top Buys
| 1 | +$80.3M | |
| 2 | +$65.6M | |
| 3 | +$61.6M | |
| 4 |
Exact Sciences
EXAS
|
+$59M |
| 5 |
Dyne Therapeutics
DYN
|
+$55.6M |
Top Sells
| 1 | +$127M | |
| 2 | +$101M | |
| 3 | +$80M | |
| 4 |
VRNA
Verona Pharma
VRNA
|
+$55.9M |
| 5 |
AKRO
Akero Therapeutics
AKRO
|
+$53.9M |
Sector Composition
| 1 | Healthcare | 99.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Nurix Therapeutics
NRIX
$1.67B
| $67.5M | 1.24% |
3,555,877
+2,139,728
|
|
||
27
Solid Biosciences
SLDB
$478M
| $66.7M | 1.22% |
11,833,539
|
|
||
|
BLTE
28
Belite Bio
BLTE
$6.67B
| $66.3M | 1.21% |
414,239
+364,451
|
|
||
|
ABVX
29
Abivax
ABVX
$9.23B
| $61.8M | 1.13% |
458,343
+69,735
|
|
||
30
Invivyd
IVVD
$482M
| $53.8M | 0.99% |
+21,785,166
|
|
||
31
enGene Holdings
ENGN
$652M
| $53M | 0.97% |
5,869,076
+3,771,840
|
|
||
32
Repligen
RGEN
$7.09B
| $51.7M | 0.95% |
315,541
+45,113
|
|
||
33
Immunovant
IMVT
$5.51B
| $50.7M | 0.93% |
1,994,890
+407,000
|
|
||
34
Intuitive Surgical
ISRG
$178B
| $49.8M | 0.91% |
87,919
+35,800
|
|
||
|
SION
35
Sionna Therapeutics
SION
$1.54B
| $48.5M | 0.89% |
1,179,098
|
|
||
36
Neurocrine Biosciences
NBIX
$13.4B
| $47M | 0.86% |
331,050
-119,000
|
|
||
37
Danaher
DHR
$145B
| $45.8M | 0.84% |
+200,000
|
|
||
|
ORKA
38
Oruka Therapeutics
ORKA
$1.69B
| $44.8M | 0.82% |
1,476,501
+208,480
|
|
||
39
CytomX Therapeutics
CTMX
$859M
| $41.2M | 0.76% |
9,680,185
|
|
||
|
OMDA
40
Omada Health Inc
OMDA
$783M
| $37.8M | 0.69% |
2,396,330
|
|
||
|
CDTX
41
DELISTED
Cidara Therapeutics
CDTX
| $36.5M | 0.67% |
+165,131
|
|
||
42
Disc Medicine
IRON
$2.31B
| $35.8M | 0.66% |
+450,743
|
|
||
|
DRUG
43
Bright Minds Biosciences
DRUG
$776M
| $35.1M | 0.64% |
449,290
|
|
||
44
Penumbra
PEN
$13.3B
| $34.4M | 0.63% |
110,529
-110,018
|
|
||
45
Alto Neuroscience
ANRO
$666M
| $31.8M | 0.58% |
1,784,393
+1,629,027
|
|
||
|
CAI
46
Caris Life Sciences
CAI
$5.6B
| $30.7M | 0.56% |
1,136,206
+38,043
|
|
||
47
Jazz Pharmaceuticals
JAZZ
$11.6B
| $28.9M | 0.53% |
+170,000
|
|
||
48
Palisade Bio
PALI
$260M
| $28.3M | 0.52% |
+12,050,000
|
|
||
49
RAPT Therapeutics
RAPT
| $28M | 0.51% |
825,890
+642,000
|
|
||
|
PVLA
50
Palvella Therapeutics
PVLA
$1.6B
| $27.9M | 0.51% |
266,287
-128,806
|
|